Trials / Completed
CompletedNCT01814774
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a retrospective chart review to evaluate the doses of botulinum Type A toxins BOTOX® (onabotulinumtoxinA) and Xeomin® (incobotulinumtoxinA) used for the treatment of Cervical Dystonia and Blepharospasm in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No treatment (intervention) was administered. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2013-03-20
- Last updated
- 2014-07-03
- Results posted
- 2014-07-03
Locations
2 sites across 2 countries: Norway, United Kingdom
Source: ClinicalTrials.gov record NCT01814774. Inclusion in this directory is not an endorsement.